Skip to content
drillr.ai
Sign up

APRE

Aprea Therapeutics, Inc.

NASDAQ · Healthcare · Biotechnology · US

$0.79
−1.49%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue——1.5M583.2K—
Cost of Revenue5.4K—9.4M7.1K16.4M
Gross Profit(5.4K)—(7.9M)576.2K(16.4M)
Operating Expenses
R&D Expense6.7M7.0M9.4M7.6M92.4M
SG&A Expense6.5M6.5M6.5M8.4M21.0M
General & Admin Expense6.5M6.5M6.5M8.4M21.0M
Selling & Marketing Expense———(7.1K)—
Other Expenses(5.2K)(285.8K)(9.4M)—(16.4M)
Total Operating Expenses13.2M13.2M6.5M16.0M97.0M
Cost and Expenses13.2M13.2M15.8M16.1M113.4M
Operating Income (EBIT)(13.2M)(13.2M)(14.3M)(15.5M)(113.4M)
Non-Operating
Interest Income763.0K652.1K1.3M1.2M448.7K
Interest Expense————448.7K
Net Interest Income763.0K652.1K1.3M1.2M—
Other Non-Op Income/Expense915.8K634.3K1.4M1.2M730.2K
Non-Operating Income (excl Interest)(915.8K)(634.3K)(1.4M)(1.2M)(76.0M)
EBT (Pre-Tax Income)(12.3M)(12.6M)(13.0M)(14.3M)(112.7M)
Income Tax Expense—————
Bottom Line
Net Income(12.3M)(12.6M)(13.0M)(14.3M)(112.7M)
Earnings from Cont. Ops(12.3M)(12.6M)(13.0M)(14.3M)(112.7M)
Earnings from Discont. Ops—————
Bottom Line Net Income(12.3M)(12.6M)(13.0M)(14.3M)(112.7M)
Per Share
Basic EPS($1.29)($1.93)($2.35)($3.95)($1,359.79)
Diluted EPS($1.29)($1.93)($2.35)($3.95)($1,359.79)
Revenue Per Share$0.00$0.00$0.27$0.16$0.00
Shares
Basic Shares Outstanding53.5M6.5M5.5M3.6M82852
Diluted Shares Outstanding53.5M6.5M5.5M3.6M82852
Profitability Metrics
EBITDA(12.3M)(12.6M)(12.9M)(14.3M)(37.4M)
D&A22.0K21.7K22.3K7.1K4.4K
EBIT(12.3M)(12.6M)(13.0M)(14.3M)(37.4M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026